VIVUS: Vivus responds to reports of "disappointing results" with MUSE (alprostadil)

0 Comments | M2 Presswire, June, 1998

M2 PRESSWIRE-8 June 1998-VIVUS: Vivus responds to reports of "disappointing results" with MUSE (alprostadil) (C)1994-98 M2 COMMUNICATIONS LTD RDATE:050698 MOUNTAIN VIEW, CA -- VIVUS, Inc. (Nasdaq: VVUS) today responded to media reports about "disappointing results" data presented at the American Urological Association (AUA) annual meeting earlier this week in San Diego, CA.

VIVUS would like to refer patients and physicians to the efficacy data of MUSE amassed from 71 worldwide clinical trial sites and involving nearly 1,800 patients. Additional new data on the efficacy of MUSE in clinical practice are scheduled for presentation at the American Diabetes Association meeting to be held June 13-16 in Chicago, IL. The abstract presented at the AUA by researchers from...